ATG3 and inflammatory bowel disease: Activated Atg3- and Atg5-deficient T cells differentiated in vitro into TH9 cells show increased production of IL-9 compared to their WT counterparts [229], and mutations in core autophagy genes increase the risk for development of inflammatory bowel disease (IBD) in humans [218].